Cargando…

Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties

There are limited numbers of models to study hepatocellular carcinoma (HCC) in vivo in immunocompetent hosts. In an effort to develop a cell line with improved tumorigenicity, we derived a new cell line from Hepa1-6 cells through an in vivo passage in C57BL/6 mice. The resulting Dt81Hepa1-6 cell lin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lacoste, Benoit, Raymond, Valérie-Ann, Cassim, Shamir, Lapierre, Pascal, Bilodeau, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289561/ https://www.ncbi.nlm.nih.gov/pubmed/28152020 http://dx.doi.org/10.1371/journal.pone.0171215

Ejemplares similares

Metabolite profiling identifies a signature of tumorigenicity in hepatocellular carcinoma
por: Cassim, Shamir, et al.
Publicado: (2018)

Protection against Acute Hepatocellular Injury Afforded by Liver Fibrosis Is Independent of T Lymphocytes
por: Lacoste, Benoit, et al.
Publicado: (2016)

From in vivo to in vitro: Major metabolic alterations take place in hepatocytes during and following isolation
por: Cassim, Shamir, et al.
Publicado: (2017)

Novel Immunotherapies for Autoimmune Hepatitis
por: Cassim, Shamir, et al.
Publicado: (2017)

Upregulation of Krebs cycle and anaerobic glycolysis activity early after onset of liver ischemia
por: Chan, Tom S., et al.
Publicado: (2018)

Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells
por: Fujikawa, Akihiro, et al.
Publicado: (2017)

The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma
por: Chen, Jia-Jie, et al.
Publicado: (2015)

A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li‐7
por: Sato, Yukako, et al.
Publicado: (2019)

Rapamycin Response in Tumorigenic and Non-Tumorigenic Hepatic Cell Lines
por: Jimenez, Rosa H., et al.
Publicado: (2009)

Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy
por: García-Heredia, José M., et al.
Publicado: (2016)

Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal
por: Wang, Tao, et al.
Publicado: (2016)

Establishment of Highly Tumorigenic Human Colorectal Cancer Cell Line (CR4) with Properties of Putative Cancer Stem Cells
por: Rowehl, Rebecca A., et al.
Publicado: (2014)

MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype
por: Tambay, Vincent, et al.
Publicado: (2021)

The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells
por: Redmer, Torben, et al.
Publicado: (2014)

Identification of cellular genes and pathways important for tumorigenicity of hepatocellular carcinoma cell lines by proteomic profiling
por: Zamani, Ali, et al.
Publicado: (2017)

Identification of a gene set that maintains tumorigenicity of the hepatocellular carcinoma cell line Li-7
por: Seyama, Yusuke, et al.
Publicado: (2023)

Metabolomics-Guided Identification of a Distinctive Hepatocellular Carcinoma Signature
por: Tambay, Vincent, et al.
Publicado: (2023)

Neural stemness contributes to cell tumorigenicity
por: Xu, Liyang, et al.
Publicado: (2021)

Tumorigenicity of adenovirus-5-transformed BHK cell lines with various transformation-associated properties.
por: Meager, A., et al.
Publicado: (1978)

Correction: The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells
Publicado: (2014)

TAZ Controls Helicobacter pylori-Induced Epithelial–Mesenchymal Transition and Cancer Stem Cell-Like Invasive and Tumorigenic Properties
por: Tiffon, Camille, et al.
Publicado: (2020)

Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer
por: He, Ningning, et al.
Publicado: (2016)

Immune-Mediated Hepatitis During Immune Checkpoint Inhibitor cancer Immunotherapy: Lessons From Autoimmune Hepatitis and Liver Immunology
por: Hercun, Julian, et al.
Publicado: (2022)

Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells
por: Gong, C, et al.
Publicado: (2013)

Cell softness regulates tumorigenicity and stemness of cancer cells
por: Lv, Jiadi, et al.
Publicado: (2020)

Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7
por: Karabicici, Mustafa, et al.
Publicado: (2021)

Epigenetic mechanisms of tumorigenicity manifesting in stem cells
por: Tung, Po-Yuan, et al.
Publicado: (2014)

The Tumorigenic Potential of Human Pluripotent Stem Cells
por: Lezmi, Elyad, et al.
Publicado: (2022)

EMT and Acquisition of Stem Cell-Like Properties Are Involved in Spontaneous Formation of Tumorigenic Hybrids between Lung Cancer and Bone Marrow-Derived Mesenchymal Stem Cells
por: Xu, Mei-Hua, et al.
Publicado: (2014)

Overexpression of SIRT6 attenuates the tumorigenicity of hepatocellular carcinoma cells
por: Wang, Yadong, et al.
Publicado: (2017)

Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
por: Park, Mijin, et al.
Publicado: (2022)

Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine
por: Qiao, Yu, et al.
Publicado: (2020)

Significance of CD133 as a cancer stem cell markers focusing on the tumorigenicity of pancreatic cancer cell lines
por: Lee, Hyun Joo, et al.
Publicado: (2011)

UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma
por: Wang, Yanchen, et al.
Publicado: (2023)

Suppression of Cell Tumorigenicity by Non-neural Pro-differentiation Factors via Inhibition of Neural Property in Tumorigenic Cells
por: Yang, Xiaoli, et al.
Publicado: (2021)

Berberine Suppresses Stemness and Tumorigenicity of Colorectal Cancer Stem-Like Cells by Inhibiting m(6)A Methylation
por: Zhao, Ziyi, et al.
Publicado: (2021)

YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma
por: Bai, Yang, et al.
Publicado: (2019)

Growth and transplantability of clonally related tumorigenic murine cell lines.
por: Walker, J. R.
Publicado: (1978)

Selective Targeting of Tumorigenic Cancer Cell Lines by Microtubule Inhibitors
por: Abdullah, Newaj M., et al.
Publicado: (2009)

Tumorigenicity-associated characteristics of human iPS cell lines
por: Yasuda, Satoshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5ng3i20co8j5pabgbh1riqa1f1